Rationally engineered Troponin C modulates in vivo cardiac function and performance in health and disease
Heart contraction, which is decreased in disease, is determined by Ca2+binding to troponin C. Here, the authors combine a protein engineering approach with gene therapy to modulate heart contractility in mice with the use of rationally designed Troponin C variants, suggesting a new therapy for disea...
Main Authors: | Vikram Shettigar, Bo Zhang, Sean C. Little, Hussam E. Salhi, Brian J. Hansen, Ning Li, Jianchao Zhang, Steve R. Roof, Hsiang-Ting Ho, Lucia Brunello, Jessica K. Lerch, Noah Weisleder, Vadim V. Fedorov, Federica Accornero, Jill A. Rafael-Fortney, Sandor Gyorke, Paul M. L. Janssen, Brandon J. Biesiadecki, Mark T. Ziolo, Jonathan P. Davis |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2016-02-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms10794 |
Similar Items
-
THE ROLE OF ENGINEERED CARDIAC TROPONIN C L48Q IN HEALTH AND DISEASE
by: Shettigar, Vikram
Published: (2016) -
Integration of Troponin I Phosphorylations to Modulate Cardiac Function
by: Salhi, Hussam E., Salhi
Published: (2016) -
The Role of Troponin C in the Heart
by: Little, Sean Carl
Published: (2012) -
Secondary phosphorylation in myocytes expressing FLAG-tagged and non-tagged phospho-mimetic cardiac troponin I
by: Sarah E. Lang, et al.
Published: (2017-12-01) -
Myofilament Calcium Sensitivity: Mechanistic Insight into TnI Ser-23/24 and Ser-150 Phosphorylation Integration
by: Hussam E Salhi, et al.
Published: (2016-12-01)